Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Diclofenac (DCF) is a well-known and widely used non-steroidal anti-inflammatory drug (NSAID), with a range of actions which are of interest in an oncological context. While there has long been an interest in the use of NSAIDs in chemoprevention, there is now emerging evidence that such drugs may ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantziarka, Pan, Sukhatme, Vidula, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720497/
https://www.ncbi.nlm.nih.gov/pubmed/26823679
http://dx.doi.org/10.3332/ecancer.2016.610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720497/
https://www.ncbi.nlm.nih.gov/pubmed/26823679
http://dx.doi.org/10.3332/ecancer.2016.610

Ejemplares similares